Biomedical Engineering Reference
In-Depth Information
[166] Yoshikawa H, Takada K, Satoh Y, Naruse N, Muranishi S. Development of interferon
suppositories. Enhanced rectal absorption of human fibroblast interferon by fusogenic
lipid via lymphotropic delivery in rat. Pharm Res 1986;3:116-17.
[167] Utoguchi N, Watanabe Y, Shida T, Matsumoto M. Nitric oxide donors enhance rectal
absorption of macromolecules in rabbits. Pharm Res 1998;15:870-6.
[168] Onuki Y, Morishita M, Takayama K, Tokiwa S, Chiba Y, Isowa K, et al.
In vivo
effects of
highly purified docosahexaenoic acid on rectal insulin absorption. Int J Pharm 2000;198:
147-56.
[169] Uchida T, Toida Y, Sakakibara S, Miyanaga Y, Tanaka H, Nishikata M, et al. Preparation
and characterization of insulin-loaded acrylic hydrogels containing absorption enhanc-
ers. Chem Pharm Bull 2001;49:1261-6.
[170] Kouji K, Iori H, Hirono K, Naoki U, Makiko F, Yoshiteru W. Pharmacokinetics and
pharmacodynamics of human chorionic gonadotropin (hCG) after rectal administration
of hollow-type suppositories containing hCG. Biol Pharm Bull 2002;25:678-81.
[171] Miyake M, Kamada N, Oka Y, Mukai T, Minami T, Toguchi H, et al. Development of sup-
pository formulation safely improving rectal absorption of rebamipide, a poorly absorb-
able drug, by utilizing sodium laurate and taurine. J Control Release 2004;99:63-71.
[172] Nishihata T, Rytting JH, Kamada A, Higuchi T, Routh M, Caldwell L. Enhancement of
rectal absorption of insulin using salicylates in dogs. J Pharm Pharmacol 1983;35:148-51.
[173] Uchiyama T, Sugiyama T, Quan Y-S, Yamamoto A, Muranishi S. Enhancement effects
of various absorption enhancers on the transport of insulin across the intestinal mem-
brane. The 12th Japan Society of DDS (Kyoto) 1996:7.
[174] Yoshioka S, Caldwell L, Higuchi T. Enhanced rectal bioavailability of polypeptides using
sodium 5-methoxysalicylate as an absorption promoter. J Pharm Sci 1982;71:593-4.
[175] Ziv E, Eldor A, Kleinman Y, Bar-On H, Kidron M. Bile salts facilitate the absorption of
heparin from the intestine. Biochem Pharmacol 1983;32:773-9.
[176] Hosny EA. Relative hypoglycemia of rectal insulin suppositories containing deoxycho-
lic acid, sodium taurocholate, polycarbophil, and their combinations in diabetic rabbits.
Drug Dev Ind Pharm 1999;25:745-52.
[177] Ehab HA, Zohair Al-MMH, Mohammed MES, Mamdouh SYS, Rhman AAAM.
Evaluation of efficiency of insulin suppository formulations containing sodium salicylate
or sodium cholate in insulin dependent diabetic patients. Boll Chim Farm 2003;142:361-6.
[178] Yamamoto A, Hayakawa E, Kato Y, Nishiura A, Lee VH. A mechanistic study on
enhancement of rectal permeability to insulin in the albino rabbit. J Pharmacol Exp
Ther 1992;263:25-30.
[179] Hoogdalem EJ, Heijliger-Feijien CD, Boer AG, Verhoef JC, Breimer DD. Rectal
absorption enhancement of des-enkephalin--endorphin (DE--E) by medium-chain
glycerides and EDTA in conscious rats. Pharm Res 1989;6:91-5.
[180] Miyake M, Nishihata T, Wada N, Takeshima E, Kamada A. Rectal absorption of lyso-
zyme and heparin in rabbits in the presence of non-surfactant adjuvants. Chem Pharm
Bull 1984;32:2020-5.
[181] Kamada A, Nishihata T, Kim S, Yamamoto M, Yata N. Study of enamine derivatives
of phenylglycine as adjuvants for the rectal absorption of insulin. Chem Pharm Bull
1981;29:2012-19.
[182] Kim S, Kamada A, Higuchi T, Nishihata T. Effect of enamine derivatives on the rectal
absorption of insulin in dogs and rabbits. J Pharm Pharmacol 1983;35:100-3.
[183] Yagi T, Hakui N, Yamasaki Y, Kawamori R, Shichiri M, Abe H, et al. Insulin suppository:
enhanced rectal absorption of insulin using an enamine derivative as a new promoter.
J Pharm Pharmacol 1983;35:177-8.
Search WWH ::
Custom Search